We are live on ! Find out more
KTC

Kistler-Tiffany Companies Portfolio holdings

AUM $616M
1-Year Est. Return 16.74%
This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+16.74%
3 Year Est. Return
+52%
5 Year Est. Return
+77.66%
10 Year Est. Return
+209.93%
AUM
$263M
AUM Growth
+$21.2M
Cap. Flow
+$14.5M
Cap. Flow %
5.51%
Top 10 Hldgs %
50.86%
Holding
604
New
28
Increased
145
Reduced
84
Closed
25

Top Buys

Rank Stock Value
1
MLAB icon
Mesa Laboratories
MLAB
+$6.54M
2
VV icon
Vanguard Morningstar Large-Cap ETF
VV
+$4.83M
3
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$1.05M
4
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$973K
5
SCHM icon
Schwab US Mid-Cap ETF
SCHM
+$826K

Top Sells

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$2.88M
2
EXC icon
Exelon
EXC
+$317K
3
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$313K
4
VZ icon
Verizon
VZ
+$279K
5
RTX icon
RTX Corp
RTX
+$272K

Sector Composition

Rank Sector Weight
1 Healthcare 9.99%
2 Technology 8.32%
3 Consumer Staples 4.58%
4 Communication Services 4.11%
5 Financials 3.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GH icon
451
Guardant Health
GH
$22.2B
$9K ﹤0.01%
100
– –
KBE icon
452
State Street SPDR S&P Bank ETF
KBE
$1.74B
$9K ﹤0.01%
205
– –
LIN icon
453
Linde
LIN
$221B
$9K ﹤0.01%
46
– –
MPLX icon
454
MPLX
MPLX
$60.8B
$9K ﹤0.01%
279
– –
PII icon
455
Polaris
PII
$3.9B
$9K ﹤0.01%
99
– –
PRFZ icon
456
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.9B
$9K ﹤0.01%
360
– –
PSEC icon
457
Prospect Capital
PSEC
$1.15B
$9K ﹤0.01%
1,334
– –
RVTY icon
458
Revvity
RVTY
$13.2B
$9K ﹤0.01%
95
– –
SCHW
459
Charles Schwab
SCHW
$189B
$9K ﹤0.01%
214
– –
RTN
460
DELISTED
Raytheon Company
RTN
$9K ﹤0.01%
49
-131
-73% -$23.6K
DVY icon
461
iShares Select Dividend ETF
DVY
$23.7B
$8K ﹤0.01%
79
– –
FMC icon
462
FMC
FMC
$1.28B
$8K ﹤0.01%
+100
New +$7.85K
HUM icon
463
Humana
HUM
$46.7B
$8K ﹤0.01%
29
– –
LGIH icon
464
LGI Homes
LGIH
$1.32B
$8K ﹤0.01%
116
– –
LUMN icon
465
Lumen
LUMN
$6.49B
$8K ﹤0.01%
658
– –
NTB icon
466
Bank of N.T. Butterfield & Son
NTB
$2.5B
$8K ﹤0.01%
248
– –
PGR icon
467
Progressive
PGR
$121B
$8K ﹤0.01%
101
– –
QQQ icon
468
Invesco QQQ Trust
QQQ
$481B
$8K ﹤0.01%
43
– –
RPM icon
469
RPM International
RPM
$14.7B
$8K ﹤0.01%
125
– –
WINA icon
470
Winmark
WINA
$1.24B
$8K ﹤0.01%
48
– –
CVET
471
DELISTED
Covetrus, Inc. Common Stock
CVET
$8K ﹤0.01%
325
– –
CARE icon
472
Carter Bankshares
CARE
$717M
$7K ﹤0.01%
376
– –
DOV icon
473
Dover
DOV
$28B
$7K ﹤0.01%
71
– –
EWU icon
474
iShares MSCI United Kingdom ETF
EWU
$4.14B
$7K ﹤0.01%
219
– –
F icon
475
Ford
F
$55.1B
$7K ﹤0.01%
727
+227
+45% +$2.24K
17 18
19
20 21

Similar funds

FANJ
Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return
NWM
NEIRG Wealth Management North Andover, Massachusetts $542M AUM 10.92% 1-Year Est. Return
KC
KCL Capital New York $714M AUM 77.46% 1-Year Est. Return
EWM
Endurance Wealth Management Providence, Rhode Island $731M AUM 18.41% 1-Year Est. Return
SAM
Sabadell Asset Management Sant Cugat Del Valles, Spain $482M AUM 27.83% 1-Year Est. Return
TWI
Thomas White International Chicago, Illinois $480M AUM 11.77% 1-Year Est. Return
TF
TimeScale Financial Danvers, Massachusetts $463M AUM 12.48% 1-Year Est. Return
ECI
EFG Capital International Miami, Florida $432M AUM

Kistler-Tiffany Companies's Q2 2019 Portfolio in Review

As of Q2 2019, Kistler-Tiffany Companies held 604 positions worth $263M, up 8.8% from $242M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Kistler-Tiffany Companies deployed $14.5M of net new capital in Q2 2019, opening 28 new positions and adding to 145 existing holdings. Its largest new stake was Dow Inc: 6,430 shares worth $317K.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was West Pharmaceutical, an estimated $2.88M trimmed.

  • Kistler-Tiffany Companies's largest Q2 2019 buy was Dow Inc: 6,430 shares worth $317K.
  • Kistler-Tiffany Companies added most to Mesa Laboratories in Q2 2019, an estimated $6.54M increase.
  • Kistler-Tiffany Companies's biggest Q2 2019 reduction was West Pharmaceutical, cutting an estimated $2.88M.
  • Kistler-Tiffany Companies fully exited Blackstone in Q2 2019, selling an estimated $251K.
  • Kistler-Tiffany Companies's ten largest holdings make up 51% of its $263M portfolio in Q2 2019.
  • Kistler-Tiffany Companies opened 28 new positions and closed 25 in Q2 2019.
  • Kistler-Tiffany Companies's portfolio value rose 8.8% quarter-over-quarter to $263M.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2019, filed 22 Jul 2019.